These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 2757931
1. Non-symmetric subcutaneous lipomatosis associated with familial combined hyperlipidaemia. Rubinstein A, Goor Y, Gazit E, Cabili S. Br J Dermatol; 1989 May; 120(5):689-94. PubMed ID: 2757931 [Abstract] [Full Text] [Related]
2. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Hunt SC, Wu LL, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR. Arteriosclerosis; 1989 May; 9(3):335-44. PubMed ID: 2497719 [Abstract] [Full Text] [Related]
4. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained? Brouwers MC, de Graaf J, van Greevenbroek MM, Georgieva AM, van der Kallen CJ, Ter Avest E, Stehouwer CD, Stalenhoef AF, de Bruin TW. Clin Sci (Lond); 2008 Mar 24; 114(5):393-401. PubMed ID: 17953518 [Abstract] [Full Text] [Related]
5. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB. J Lipid Res; 1983 Feb 24; 24(2):147-55. PubMed ID: 6403642 [Abstract] [Full Text] [Related]
6. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging. Kuromori Y, Okada T, Iwata F, Hara M, Noto N, Harada K. J Atheroscler Thromb; 2002 Feb 24; 9(6):314-20. PubMed ID: 12560593 [Abstract] [Full Text] [Related]
7. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia. Jarauta E, Mateo-Gallego R, Gilabert R, Plana N, Junyent M, de Groot E, Cenarro A, Masana L, Ros E, Civeira F. Nutr Metab Cardiovasc Dis; 2012 Jul 24; 22(7):591-7. PubMed ID: 21196102 [Abstract] [Full Text] [Related]
8. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Hoffer MJ, Bredie SJ, Boomsma DI, Reymer PW, Kastelein JJ, de Knijff P, Demacker PN, Stalenhoef AF, Havekes LM, Frants RR. Atherosclerosis; 1996 Jan 26; 119(2):159-67. PubMed ID: 8808493 [Abstract] [Full Text] [Related]
9. Lipid profile in the first-degree relatives of patients with precocious coronary heart disease in Rohtak area (Northern India). Ahlawat S, Gupta S, Siwach SB, Mohan S. Angiology; 1995 Jan 26; 46(1):75-81. PubMed ID: 7818160 [Abstract] [Full Text] [Related]
10. High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia. de Graaf J, van der Vleuten GM, ter Avest E, Dallinga-Thie GM, Stalenhoef AF. J Clin Endocrinol Metab; 2007 Apr 26; 92(4):1269-75. PubMed ID: 17227806 [Abstract] [Full Text] [Related]
11. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia. Boquist S, Karpe F, Danell-Toverud K, Hamsten A. Atherosclerosis; 2002 May 26; 162(1):163-70. PubMed ID: 11947910 [Abstract] [Full Text] [Related]
12. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF, McGladdery SH, McNeely MJ, Austin MA, Motulsky AG, Brunzell JD. Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1289-94. PubMed ID: 12750118 [Abstract] [Full Text] [Related]
13. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia]. Sziegoleit W, Wichmann T, Block HU, Taube C, Mest HJ. Wien Klin Wochenschr; 1991 Jul 01; 103(8):227-31. PubMed ID: 1858388 [Abstract] [Full Text] [Related]
15. Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Williams RR, Hunt SC, Hopkins PN, Wu LL, Hasstedt SJ, Berry TD, Barlow GK, Stults BM, Schumacher MC, Ludwig EH. Am J Hypertens; 1993 Nov 01; 6(11 Pt 2):319S-327S. PubMed ID: 8297539 [Abstract] [Full Text] [Related]
16. Familial multiple lipomatosis. Keskin D, Ezirmik N, Celik H. Isr Med Assoc J; 2002 Dec 01; 4(12):1121-3. PubMed ID: 12516905 [Abstract] [Full Text] [Related]
17. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Coon H, Myers RH, Borecki IB, Arnett DK, Hunt SC, Province MA, Djousse L, Leppert MF. Arterioscler Thromb Vasc Biol; 2000 Oct 01; 20(10):2275-80. PubMed ID: 11031215 [Abstract] [Full Text] [Related]
18. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. Liacouras CA, Coates PM, Gallagher PR, Cortner JA. J Pediatr; 1993 Mar 01; 122(3):477-82. PubMed ID: 8441109 [Abstract] [Full Text] [Related]
19. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Kwiterovich PO, White S, Forte T, Bachorik PS, Smith H, Sniderman A. Arteriosclerosis; 1987 Mar 01; 7(3):211-25. PubMed ID: 3593067 [Abstract] [Full Text] [Related]
20. Determinants of low HDL levels in familial combined hyperlipidemia. Soro A, Jauhiainen M, Ehnholm C, Taskinen MR. J Lipid Res; 2003 Aug 01; 44(8):1536-44. PubMed ID: 12777471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]